2016
DOI: 10.1590/abd1806-4841.20163867
|View full text |Cite
|
Sign up to set email alerts
|

Scleroderma en coup de sabre treated with polymethylmethacrylate - Case report

Abstract: The scleroderma en coup de sabre is a variant of localized scleroderma that occurs preferentially in children. The disease progresses with a proliferative and inflammatory phase and later atrophy and residual deformity, which are treated with surgical techniques such as injectable fillers, transplanted or autologous fat grafting and resection of the lesion. Among the most widely used fillers is hyaluronic acid. However, there are limitations that motivate the search for alternatives, such as polymethylmethacry… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 5 publications
(10 reference statements)
0
15
0
Order By: Relevance
“…Current dermatological medical treatments for localized scleroderma (e.g., immune suppressants) are usually conservative and often do not yield thoroughly satisfying outcomes for patients. Furthermore, most existing research about surgical management options (e.g., filler [ 7 8 ], artificial dermis [ 9 ], artificial bone [ 10 ], hair transplantation [ 11 12 ], or fat or dermofat graft [ 13 14 15 16 ]) are case reports and, thus, lack a systematic analysis. None of our patients experienced significant clinical improvement with medication and were subsequently referred from the dermatology department.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Current dermatological medical treatments for localized scleroderma (e.g., immune suppressants) are usually conservative and often do not yield thoroughly satisfying outcomes for patients. Furthermore, most existing research about surgical management options (e.g., filler [ 7 8 ], artificial dermis [ 9 ], artificial bone [ 10 ], hair transplantation [ 11 12 ], or fat or dermofat graft [ 13 14 15 16 ]) are case reports and, thus, lack a systematic analysis. None of our patients experienced significant clinical improvement with medication and were subsequently referred from the dermatology department.…”
Section: Discussionmentioning
confidence: 99%
“…Because we only reviewed a small number of cases during a short follow-up period, larger studies are needed in the future. Additionally, other new reconstruction methods for treating localized scleroderma, including filler [ 7 8 ], artificial dermis [ 9 ], artificial bone [ 10 ], and hair transplantation [ 11 12 ] would be beneficial to this patient population.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nonpermanent fillers, such as HA and poly-L-lactic acid (PLLA), have been successfully employed to treat atrophy linked to linear morphea, scleroderma, LE, and LE panniculitis (LEP) (Gupta, Bhari, Verma, & Gupta, 2017;Ponzo, Carruthers, & Humphrey, 2017;Thareja, Sadhwani, & Alan Fenske, 2015) Permanent fillers such as polymethylmethacrylate and polyacrylamide hydrogel have also yielded excellent results in scleroderma en coup de sabre and LEP-induced subcutaneous tissue atrophy (Franco, Serra, Lima, D'Acri, & Martins, 2016;Gupta et al, 2017).…”
Section: Fillersmentioning
confidence: 99%
“…Permanent fillers such as polymethylmethacrylate and polyacrylamide hydrogel have also yielded excellent results in scleroderma en coup de sabre and LEP‐induced subcutaneous tissue atrophy (Franco, Serra, Lima, D'Acri, & Martins, ; Gupta et al, ). Delayed gel induration is one of the principal complications of polyacrylamide filler use, resulting in significant concerns in CTDs (Gupta et al, ).…”
Section: Introductionmentioning
confidence: 99%